Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
Abstract Objective The TGF‐β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in acti...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.7368 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1825206496873414656 |
---|---|
author | Elizabeth T. Evans Emily F. Page Alex Seok Choi Zainab Shonibare Andrea G. Kahn Rebecca C. Arend Karthikeyan Mythreye |
author_facet | Elizabeth T. Evans Emily F. Page Alex Seok Choi Zainab Shonibare Andrea G. Kahn Rebecca C. Arend Karthikeyan Mythreye |
author_sort | Elizabeth T. Evans |
collection | DOAJ |
description | Abstract Objective The TGF‐β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in activin (INHBA/ Inhibin‐βA and INHBB/ Inhibin‐βB) between malignant and ovarian tissues at the RNA and protein level and assess the relationship between activin and immune cells in EOC. Methods Publicly available RNA sequencing data were accessed from GEO (#GSE143897) with normalization and quantification performed via DESeq2. Immune gene expression profile was further explored within the TCGA‐OV cohort derived from The Cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to evaluate activin A and T‐cell markers CD8 and FoxP3 at the protein level. ELISA to activin‐A was used to assess levels in the ascites of advanced EOC patients. Kaplan–Meier curves were generated to visualize survival outcomes. Results Gene expression levels of components of the activin signaling pathway were elevated within EOC when compared to a benign cohort, with differences in activin type I/II receptor gene profiles identified. Additionally, INHBA gene expression was linked to lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of CD8 and FOXP3 staining with activin A at the protein level in both primary and metastatic epithelial ovarian cancer samples. Furthermore, Activin‐A (inhibin‐βA) is significantly elevated in EOC patient ascites. Conclusion INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration. Our findings suggest that activin‐A may play a role in suppressing anti‐tumor immunity in EOC, highlighting its potential as a therapeutic target. |
format | Article |
id | doaj-art-9a6ef7941d9d4424a939ec5da6563127 |
institution | Kabale University |
issn | 2045-7634 |
language | English |
publishDate | 2024-09-01 |
publisher | Wiley |
record_format | Article |
series | Cancer Medicine |
spelling | doaj-art-9a6ef7941d9d4424a939ec5da65631272025-02-07T09:08:08ZengWileyCancer Medicine2045-76342024-09-011317n/an/a10.1002/cam4.7368Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancerElizabeth T. Evans0Emily F. Page1Alex Seok Choi2Zainab Shonibare3Andrea G. Kahn4Rebecca C. Arend5Karthikeyan Mythreye6Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Heersink School of Medicine University of Alabama School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USADivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Heersink School of Medicine University of Alabama School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USAAbstract Objective The TGF‐β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in activin (INHBA/ Inhibin‐βA and INHBB/ Inhibin‐βB) between malignant and ovarian tissues at the RNA and protein level and assess the relationship between activin and immune cells in EOC. Methods Publicly available RNA sequencing data were accessed from GEO (#GSE143897) with normalization and quantification performed via DESeq2. Immune gene expression profile was further explored within the TCGA‐OV cohort derived from The Cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to evaluate activin A and T‐cell markers CD8 and FoxP3 at the protein level. ELISA to activin‐A was used to assess levels in the ascites of advanced EOC patients. Kaplan–Meier curves were generated to visualize survival outcomes. Results Gene expression levels of components of the activin signaling pathway were elevated within EOC when compared to a benign cohort, with differences in activin type I/II receptor gene profiles identified. Additionally, INHBA gene expression was linked to lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of CD8 and FOXP3 staining with activin A at the protein level in both primary and metastatic epithelial ovarian cancer samples. Furthermore, Activin‐A (inhibin‐βA) is significantly elevated in EOC patient ascites. Conclusion INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration. Our findings suggest that activin‐A may play a role in suppressing anti‐tumor immunity in EOC, highlighting its potential as a therapeutic target.https://doi.org/10.1002/cam4.7368activinmetastasisovarian cancertumor immune infiltration |
spellingShingle | Elizabeth T. Evans Emily F. Page Alex Seok Choi Zainab Shonibare Andrea G. Kahn Rebecca C. Arend Karthikeyan Mythreye Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer Cancer Medicine activin metastasis ovarian cancer tumor immune infiltration |
title | Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer |
title_full | Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer |
title_fullStr | Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer |
title_full_unstemmed | Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer |
title_short | Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer |
title_sort | activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer |
topic | activin metastasis ovarian cancer tumor immune infiltration |
url | https://doi.org/10.1002/cam4.7368 |
work_keys_str_mv | AT elizabethtevans activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer AT emilyfpage activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer AT alexseokchoi activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer AT zainabshonibare activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer AT andreagkahn activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer AT rebeccacarend activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer AT karthikeyanmythreye activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer |